Henan University People’s Hospital Reports Findings in Liver Cancer (Machine lea rning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a ...)
Henan University People’s Hospital Reports Findings in Liver Cancer (Machine lea rning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a ...)
扫码查看
点击上方二维码区域，可以放大扫码查看
Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Oncology - Liver Cance r is the subject of a report. According tonews reporting from Zhengzhou, People ’s Republic of China, by NewsRx journalists, research stated, “Theobjective of this study is to build and verify the performance of machine learning-based ultr asomics inpredicting the objective response to combination therapy involving a tyrosine kinase inhibitor (TKI) andanti-PD-1 antibody for individuals with unre sectable hepatocellular carcinoma (HCC). Radiomic featurescan reflect the inter nal heterogeneity of the tumor and changes in its microenvironment.”
Key words
Zhengzhou/People’s Republic of China/A sia/Amino Acids/Antibodies/Aromatic Amino Acids/Blood Proteins/Cancer/Carc inomas/Cyborgs/Drugs and Therapies/Emerging Technologies/Enzyme Inhibitors/Enzymes and Coenzymes/Health and Medicine/Hospitals/Immunoglobulins/Immunolo gy/Immunotherapy/Kinase/Liver Cancer/Machine Learning/Oncology/Proteins/P roteomics/Tyrosine/Tyrosine Kinase/Tyrosine Kinase Inhibitors
NETL
NSTL